arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

CeriBell, Inc.

CBLL Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus
$27.40
▼ -1.0% Today
as of Oct 22, 16:47 ET
Last 30 days +12.62% Sep 14 → Oct 22
$22.79 $24.10 $25.41 $26.73 $28.04 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$27.00
High
$27.87
Low
$26.77
Volume
$368,293
Avg Vol
$377,526
Mkt Cap
$901M
P/E (TTM)
—
Beta
—
52w High
$28.11
52w Low
$10.85
Div Yield
—
Shares Out
$38M

Recent Press Releases & News last 60 days · 6 items

Oct 20 · 20:05 PR GlobeNewswire
Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
Oct 18 · 19:12 Simply Wall St.
CeriBell And These 2 AI Stocks To Watch
Oct 14 · 23:22 Simply Wall St.
Is CeriBell’s (CBLL) Expanded EEG Software Deepening Its Moat in Critical Care Monitoring?
▸ Show all 6 press releases & news Free account →

CBLL earnings at a glance

CeriBell, Inc. (CBLL) is scheduled to report earnings on Tuesday, November 3, 2026 — in 11 days. Analysts expect earnings per share of -$0.50, compared with -$0.37 in the same quarter last year (-35%). The options market is pricing a move of about ±13.8% after the report, a range of roughly $23.61 to $31.19 from today's $27.40. Over its last 6 reports the stock rose the next day 2 times and fell 4, moving ±10.2% on average; after the most recent report on Aug 10, 2026 it moved +10.4%. That means options currently expect more movement than CBLL has typically delivered. CBLL beat the consensus EPS estimate in 4 of its last 6 reported quarters. Implied volatility is currently 117%. The share price of $27.40 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$11
$28
96% of range
Avg surprise (last 6)
+0.8%
Avg reaction (last 6)
-4.1%
33% positive
Latest IV / EM
117%
EM ±13.8% · $23 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.85$-1.48$-1.10$-0.73$-0.36 Actual $-1.32Actual $-1.56Actual $-1.61Actual $-1.85Actual $-0.36Est $-0.43Actual $-0.38Est $-0.40Actual $-0.37Est $-0.43Actual $-0.36Est $-0.43Actual $-0.52Est $-0.39Actual $-0.51Est $-0.45 SepMarJunSepMar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$-20M$-7M$5M$17M$30M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon Aug 10, 2026Jun/2026 $-0.51 $-0.45 -13.3% -18.4% +10.4% earnings
Mon May 11, 2026Mar/2026 $-0.52 $-0.39 -33.3% -44.4% -16.5% earnings
Tue Feb 24, 20268K 2026-02-24 $-0.36 $-0.43 +16.3% — -4.8% earnings
Tue Nov 4, 2025Sep/2025 $-0.37 $-0.43 +13.9% — +7.9% earnings
Tue Aug 5, 2025Jun/2025 $-0.38 $-0.40 +5.0% — -15.3% earnings
Thu May 8, 2025Mar/2025 $-0.36 $-0.43 +16.3% — -6.6% earnings
Mon Sep 30, 2024Sep 2024 $-1.85 — — — — financials
Sun Jun 30, 2024Jun 2024 $-1.61 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.56 — — — — financials
Sat Sep 30, 2023Sep 2023 $-1.32 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Tue Nov 3, 2026Sep/2026OTHER -$0.50-$0.37 -35.1%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$28M$26M—$23M$21M$20M—$17M
Cost of revenue$2M$3M—$3M$3M$2M—$2M
Gross profit$26M$23M—$20M$19M$18M—$15M
Operating income$-20M$-21M—$-15M$-15M$-14M—$-10M
Net income$-19M$-20M—$-13M$-14M$-13M—$-10M
EPS (diluted)$-0.51$-0.52—$-0.37$-0.38$-0.36—$-1.85

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$33M$45M$40M$24M$40M$153M$194M$14M
Inventory$7M$7M$7M$6M$6M$7M$7M$7M
Total current assets$158M$169M$187M$192M$200M$205M$217M$35M
Total assets$166M$178M$196M$200M$208M$213M$225M$47M
Long-term debt————————
Total liabilities$38M$37M$40M$35M$36M$33M$34M$36M
Total equity$128M$141M$155M$164M$172M$181M$191M$-136M

Implied volatility — last 90 days

44%112%181%250%318% Jun 07 — IV 148% · EM ±20.5%Jun 08 — IV 152% · EM ±20.1%Jun 09 — IV 114% · EM ±14.3%Jun 10 — IV 150% · EM ±17.7%Jun 11 — IV 160% · EM ±17.7%Jun 17 — IV 319% · EM ±13.3%Jun 19 — IV 56% · EM ±12.3%Jun 22 — IV 96% · EM ±20.1%Jun 23 — IV 130% · EM ±26.6%Jun 24 — IV 121% · EM ±24.2%Jun 25 — IV 94% · EM ±18.4%Jun 26 — IV 93% · EM ±17.8%Jun 29 — IV 98% · EM ±17.3%Jun 30 — IV 107% · EM ±18.5%Jul 01 — IV 100% · EM ±16.8%Jul 02 — IV 101% · EM ±16.4%Jul 03 — IV 105% · EM ±16.4%Jul 08 — IV 134% · EM ±16.8%Jul 14 — IV 228% · EM ±16.5%Jul 15 — IV 227% · EM ±13.4%Jul 20 — IV 109% · EM ±25.8%Jul 21 — IV 100% · EM ±23.2%Jul 22 — IV 101% · EM ±23.2%Jul 23 — IV 112% · EM ±25.2%Jul 24 — IV 123% · EM ±27.2%Jul 27 — IV 100% · EM ±20.8%Jul 28 — IV 93% · EM ±18.9%Jul 29 — IV 112% · EM ±22.4%Jul 30 — IV 114% · EM ±22.3%Jul 31 — IV 109% · EM ±20.8%Aug 03 — IV 136% · EM ±24.0%Aug 04 — IV 98% · EM ±16.9%Aug 05 — IV 131% · EM ±21.9%Aug 06 — IV 129% · EM ±20.8%Aug 07 — IV 85% · EM ±13.3%Aug 10 — IV 146% · EM ±20.2%Aug 11 — IV 120% · EM ±15.8%Aug 12 — IV 66% · EM ±8.3%Aug 13 — IV 106% · EM ±12.5%Aug 17 — IV 155% · EM ±12.9%Aug 19 — IV 180% · EM ±10.6%Aug 24 — IV 89% · EM ±18.6%Aug 25 — IV 87% · EM ±17.7%Aug 26 — IV 93% · EM ±18.6%Aug 27 — IV 104% · EM ±20.3%Aug 28 — IV 100% · EM ±19.2%Aug 31 — IV 113% · EM ±20.0%Sep 01 — IV 116% · EM ±19.9%Sep 02 — IV 84% · EM ±14.1%Sep 03 — IV 87% · EM ±14.1%Sep 08 — IV 98% · EM ±13.0%Sep 09 — IV 123% · EM ±15.4%Sep 10 — IV 114% · EM ±13.4%Sep 14 — IV 44% · EM ±3.7%Sep 15 — IV 47% · EM ±3.4%Sep 17 — IV 57% · EM ±2.4%Sep 21 — IV 92% · EM ±19.2%Sep 22 — IV 70% · EM ±14.3%Sep 23 — IV 91% · EM ±18.2%Sep 24 — IV 63% · EM ±12.4%Sep 25 — IV 97% · EM ±18.6%Sep 28 — IV 83% · EM ±14.7%Sep 29 — IV 74% · EM ±12.7%Sep 30 — IV 59% · EM ±9.8%Oct 01 — IV 134% · EM ±21.6%Oct 02 — IV 113% · EM ±17.7%Oct 07 — IV 129% · EM ±16.2%Oct 08 — IV 117% · EM ±13.8%

Sector peers

INMD
INMODE LTD.
$805M $14.05-0.6%
CNMD
CONMED Corporation
$1.3B $49.44+3.9%
MOVE
Corvex, Inc.
$361M $8.07-5.5%
CV
CapsoVision, Inc.
$336M $6.80+1.8%
PRKS
United Parks & Resorts Inc.
$1.5B $31.08-2.1%
ELMD
Electromed, Inc.
$236M $26.87-2.1%

CBLL earnings FAQ

When is CBLL's next earnings date?

CeriBell, Inc. is expected to report on November 3, 2026.

What is CBLL's expected move for earnings?

Options currently price a move of about ±13.8%, or $3.79 per share either way from $27.40.

How does CBLL stock usually react to earnings?

Across the last 6 reports the average next-day move was ±10.2%, up 2 times and down 4 times.

What EPS are analysts expecting from CeriBell, Inc.?

The consensus estimate is -$0.50 per share, versus -$0.37 a year ago.

What is CBLL's implied volatility?

CBLL's at-the-money implied volatility is about 117% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in